BioGaia Signs Agreement for Germany
BioGaia and HSO entered into a distribution contract for the Austrian market at the end of 2005. HSO is selling BioGaia´s products since July through pharmacies in Austria. This cooperation has now been extended to comprise also Germany.
25/10/06 BioGaia has signed an agreement with HSO Pharma, Austria giving the company exclusive rights to market BioGaia´s probiotic tablets and drops in Germany.
BioGaia and HSO entered into a distribution contract for the Austrian market at the end of 2005. HSO is selling BioGaia´s products since July through pharmacies in Austria. This cooperation has now been extended to comprise also Germany.
The products will be sold through pharmacies in Germany; the tablets under the BioGaia brand and the drops under the HSO Pharma brand. The launch will take place during next year.
"We have experienced a successful cooperation with HSO in the Austrian market. We look forward to extend it further in the German market. The launch of BioGaia´s products in Germany is important for BioGaia. The German market is big and the potential for our products is significant" says Peter Rothschild, President BioGaia AB.
HSO Pharma is experienced in probiotics and is focusing on marketing of innovative products for gut, vaginal and oral health.
BioGaia´s probiotic drops are today sold through pharmacies in 10 countries whilst the tablets are sold in 12 countries. New Contracts have been signed for a further 17 countries for the drops and 15 countries for the tablets. Launch for these markets is expected to take place during 2006 and 2007.
Upcoming webinars
The new math of functional eating in the GLP-1 era: addressing texture, nutrients, and health
Jungbunzlauer
The No-Compromise Formula: Ensuring Superior Taste in Nutrition-Focused Formulations
Biospringer by Lesaffre
Oat-Standing Ingredients - Showcasing Irish Grain Through Innovation
Tirlán Ingredients
